Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (181-190 of 258) with videos related to

Pageof 26
Sort By:
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
Breast Cancer Research and Treatment|April 28, 2016
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriersDana Madorsky-Feldman, Miri Sklair-Levy, Tamar Perri, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Nature Genetics|March 25, 2014
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Journal of Medical Genetics|December 26, 2022
Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory recordsLucy Loong, Catherine Huntley, Fiona McRonald, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.
Pageof 26

Showing results (181-190 of 258) with videos related to

Sort By:
Pageof 26
Journal of the National Cancer Institute|September 29, 2022
Cancer risks by sex and variant type in PTEN hamartoma tumor syndromeLinda A J Hendricks, Nicoline Hoogerbrugge, Arjen R Mensenkamp, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
Breast Cancer Research and Treatment|April 28, 2016
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriersDana Madorsky-Feldman, Miri Sklair-Levy, Tamar Perri, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Nature Genetics|March 25, 2014
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Journal of Medical Genetics|December 26, 2022
Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory recordsLucy Loong, Catherine Huntley, Fiona McRonald, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Journal of the National Cancer Institute|November 25, 2024
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriersShuai Li, Laura Madanat-Harjuoja, Goska Leslie, et al.
Pageof 26